Back to Search
CASEY SUMNER, PHD
PHD
Mental Health Counselor
NPI: 1194400283Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
PMID 17712235·J Am Acad Child Adolesc Psychiatry·2007
2-rct
Emerging treatment options for spinal muscular atrophy.
PMID 19210911·Curr Treat Options Neurol·2009
8-other
Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy.
PMID 19679072·Neuron·2009
7-preclinical
The role of auditory nerve innervation and dendritic filtering in shaping onset responses in the ventral cochlear nucleus.
PMID 18848923·Brain Res·2009
7-preclinical
Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice.
PMID 19158308·J Neurosci·2009
7-preclinical
Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.
PMID 19477958·Hum Mol Genet·2009
7-preclinical
Retuning of inferior colliculus neurons following spiral ganglion lesions: a single-neuron model of converging inputs.
PMID 18958527·J Assoc Res Otolaryngol·2009
7-preclinical
Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.
PMID 19420182·Clin Pediatr (Phila)·2009
4-observational
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.
PMID 19318988·J Am Acad Child Adolesc Psychiatry·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 303 SW 8TH ST
OCALA, FL 34471 - Phone
- (352) 895-0808
Quick Facts
- NPI
- 1194400283
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile